TBC1D1 and type 1 diabetes mellitus: Our GSEA analysis revealed strong evidence of a significant correlation between elevated expression of TBC1D1 and pathways related to type I diabetes mellitus, complement and coagulation cascades, allograft rejection, autoimmune thyroid disease, and graft versus host disease signaling (Figure 5A).